Organic sales increased 3% with good underlying momentum and benefits from increased demand related to COVID-19.
By segment, organic sales rose 10% in Consumer Tissue and 5% in Personal Care, but declined 15% in K-C Professional.
Combined savings from our FORCE and restructuring programs totaled $140 million, including continued strong productivity improvements.
Overall, I'm encouraged that we're improving our near-term outlook and investing significantly in the business for longer-term growth.
Third quarter adjusted gross margin was 36.2%, up 40 basis points year-on-year.
We significantly increased our growth investments and improved our market positions.
In North American consumer tissue, organic sales increased to 11% and that reflects strong demand due to the COVID-19 work from home environment and strong momentum on Kleenex facial tissue.
All in all, for the fourth quarter-for the third quarter, sorry, adjusted operating profit was down 6% and operating margin was 17.2%, down 130 basis points versus year ago.
Other manufacturing costs were higher year-on-year that included incremental costs related to COVID-19.
We had another strong quarter of achieving cost savings and returning cash to shareholders.
That's up 1% from year ago and includes a two-point drag from currency rates.
Foreign currencies were also a headwind reducing operating profit by a high single digit rate in the quarter.